Novozymes Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	533,224 shares
P/E Ratio:	65.79
Forward P/E:	37.20
EPS:	7.38 DKK
Forward EPS:	13.05 DKK
Number of Shares:	411,952,992 shares
Market Capitalization:	226,095,415,296.00 DKK

The interactive chart displays the price movement of Novozymes shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company Novozymes pays a dividend of 6.2 DKK per share. The annual dividend yield is 1.28%. The average dividend yield over the last 5 years is 1.44%. The payout ratio is 111.08%. The last paid dividend was 4.2 DKK, paid on 2025-04-04. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2025-04-04.

Dividend	Value
Dividend Amount	The company Novozymes pays a dividend of 6.2 DKK per share.
Annual Yield %:	1.28 %
Ex-dividend Date:	2025-04-04
5-Year Avg Yield %:	1.44 %
Payout Ratio:	111.08 %
Last Dividend Value:	4.2 DKK
Last Dividend Date:	2025-04-04

Analyst Forecast

Most analysts have issued a buy recommendation for Novozymes stock. The current number of analysts covering this company is 17. The highest target price is 577 DKK, while the lowest target price is 389 DKK. The median target valuation set by analysts is 510 DKK. These forecasts and recommendations provide insight into how analysts view the future stock performance of Novozymes.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Novozymes stock is: buy
Number of Analysts:	17
Highest Target Price:	577 DKK
Lowest Target Price:	389 DKK
Median Target Price:	510 DKK

Fundamental Indicators

Indicator	Data
Total Revenue:	4,057,600,000.00 DKK
Net Income:	458,500,000.00 DKK
Price-to-Book (P/B):	20.15
PEG Ratio:	/
Exchange:	Copenhagen
Industry:	Specialty Chemicals
Sector:	Basic Materials
Number of Employees:	10582
Country:	Denmark

Where to Buy Novozymes Stock?

You can purchase Novozymes stock on the Copenhagen under the ticker symbol: NSIS-B.CO. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Novozymes Stock

Indicator	Value
Company Revenue:	4,057,600,000.00 DKK
EBITDA:	1,181,699,968.00 DKK - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	7.38 DKK
Book Value Per Share:	24.09 DKK
Total Cash:	249,500,000.00 DKK
Total Cash per Share:	0.54 DKK
Total Debt:	1,699,000,064.00 DKK
Debt to Equity Ratio:	0.15
Quick Ratio	1.03
Current Ratio	1.66
Free Cash Flow	-
Operating Cash Flow	949,800,000.00 DKK
Gross Margins	52.73 %
EBITDA Margins	29.12 %
Operating Margins	25.59 %
Profit Margins	11.30 %
Return on Assets	-
Return on Equity	7.0 %
Earnings Growth (1 year)	400.0%
Revenue Growth (1 year)	26.3 %
Quarterly Earnings Year-over-Year Growth	458.6 %
Market Capitalization	226,095,415,296.00 DKK
Enterprise Value	227,786,260,480.00 DKK
EV/Revenue	56.138
EV/EBITDA	192.761
Float Shares	346,796,396 shares
Shares Outstanding	411,952,992 shares
Held Percent Insiders	0.16 %
Held Percent Institutions	43.29 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.54
Short Percentage of Float	-
Implied Shares Outstanding	467,039,008

Frequently Asked Questions (FAQ)

1️⃣ Does Novozymes pay dividends?

The company Novozymes pays a dividend of 6.2 DKK per share. At this rate, the annual yield is 1.28 %.

2️⃣ Where to buy Novozymes shares?

Novozymes shares are traded on the Copenhagen stock exchange under the ticker: NSIS-B.CO. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Novozymes shares?

According to our data, the recommendation for Novozymes shares is from a total of 17 analysts. The average target price prediction is 510 DKK per share.

4️⃣ What is the total number of shares and the value of Novozymes on the stock exchange?

The total number of Novozymes shares on the exchange is 411,952,992.00 shares, which at the current market capitalization gives the company a total valuation of 226,095,415,296.00 DKK.